CS logo
small CS logo
Tokyo-Eki Center-building Clinic

Tokyo Chuo Ku, Japan
Hospital in Chūō, Tokyo
3 Chome-2-2 Nihonbashi, Chuo City, Tokyo 103-0027

About Tokyo-Eki Center-building Clinic


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Tokyo-Eki Center-building Clinic


During the past decade, Tokyo-Eki Center-building Clinic conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo-Eki Center-building Clinic" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator and "SSP Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Tokyo-Eki Center-building Clinic


According to Clinical.Site data, the most researched conditions in "Tokyo-Eki Center-building Clinic" are "Diabetes Mellitus, Type 2" (5 trials), "Chronic Kidney Disease" (2 trials), "Asthma" (1 trials), "Diabetic Nephropathies" (1 trials) and "Dyslipidemias" (1 trials). Many other conditions were trialed in "Tokyo-Eki Center-building Clinic" in a lesser frequency.

Clinical Trials Intervention Types at Tokyo-Eki Center-building Clinic


Most popular intervention types in "Tokyo-Eki Center-building Clinic" are "Drug" (12 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "BI 685509" (2 trials), "Empagliflozin" (2 trials), "empagliflozin 25 mg" (2 trials) and "Empa + lina highdose placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Tokyo-Eki Center-building Clinic


The vast majority of trials in "Tokyo-Eki Center-building Clinic" are 12 trials for "All" genders.

Clinical Trials Status at Tokyo-Eki Center-building Clinic


Currently, there are NaN active trials in "Tokyo-Eki Center-building Clinic". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Tokyo-Eki Center-building Clinic, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tokyo-Eki Center-building Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".